Advisors Preferred, LLC Meridian Bioscience Inc Transaction History

Advisors Preferred, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$10.88 - $17.6 $169,292 - $273,856	-15,560 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$15.51 - $17.61 $147,019 - $166,925	9,479 Added 155.88%	15,560 $274,000
Q4 2018 Jan 16, 2019	BUY	$14.52 - $19.72 $88,296 - $119,917	6,081 New	6,081 $106,000
Q2 2018 Aug 07, 2018	SELL	$13.8 - $16.8 $63,521 - $77,330	-4,603 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$13.8 - $16.2 $63,521 - $74,568	4,603 New	4,603 $65,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.